
European Journal of Medicinal Chemistry p. 619 - 622 (1989)
Update date:2022-08-03
Topics:
Chapleo, Christopher B.
Doxey, John C.
Myers, Peter L.
Myers, Malcolm
Smith, Colin F. C.
Stillings, Michael R.
A preliminary communication reported on the pharmacology of the potent partial α2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central α2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard α-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in α-affinity. - α2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives
View MoreShanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Penglai Qianwei Chemical Co., Ltd.
Contact:86-535-3357802
Address:Shahelu (north), Penglai, Shandong, China
RongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Beijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
Contact:+86-(0)21-3770 9035
Address:Room 301, Building 2, Meijiabang Road 1508, Shanghai China
Doi:10.1021/jo00981a018
(1972)Doi:10.1039/c29710001496
(1971)Doi:10.1248/cpb.49.525
(2001)Doi:10.1007/BF00477394
()Doi:10.1021/acs.joc.5b01618
(2015)Doi:10.1016/S0960-894X(01)00776-4
(2002)